甘(gan)(gan)肅(su)(su)隴神(shen)戎(rong)發(fa)藥(yao)業(ye)(ye)股份有(you)限公(gong)司(si)是甘(gan)(gan)肅(su)(su)藥(yao)業(ye)(ye)投資集團有(you)限公(gong)司(si)控股的創業(ye)(ye)板上市(shi)公(gong)司(si)（股票(piao)簡稱(cheng)：隴神(shen)戎(rong)發(fa)；股票(piao)代碼：300534），主要從事(shi)中(zhong)(zhong)成(cheng)藥(yao)、保(bao)健食品的研發(fa)、生產及(ji)銷售，涉足(zu)中(zhong)(zhong)藥(yao)材種植、收購(gou)、加工、銷售及(ji)醫藥(yao)商業(ye)(ye)流通(tong)業(ye)(ye)務。公(gong)司(si)為省級高(gao)新(xin)技(ji)術(shu)企(qi)業(ye)(ye)、戰(zhan)略性新(xin)興產業(ye)(ye)首批骨干企(qi)業(ye)(ye)，搭(da)建有(you)甘(gan)(gan)肅(su)(su)省企(qi)業(ye)(ye)技(ji)術(shu)中(zhong)(zhong)心、甘(gan)(gan)肅(su)(su)省中(zhong)(zhong)藥(yao)新(xin)藥(yao)劑型研究工程實驗(yan)室、甘(gan)(gan)肅(su)(su)省中(zhong)(zhong)藥(yao)固體分散(san)制(zhi)劑重點(dian)實驗(yan)室共4個省級技(ji)術(shu)平臺，先后(hou)獲得甘(gan)(gan)肅(su)(su)省企(qi)業(ye)(ye)質量(liang)信用等級AA級企(qi)業(ye)(ye)、甘(gan)(gan)肅(su)(su)省科技(ji)進(jin)步二等獎、甘(gan)(gan)肅(su)(su)省“五一”勞動獎狀等20多項榮(rong)譽和稱(cheng)號。
公(gong)司現有(you)(you)滴(di)(di)丸(wan)劑、片(pian)(pian)劑、硬膠囊劑、膜(mo)劑4種(zhong)劑型，共有(you)(you)產(chan)(chan)品(pin)(pin)(pin)品(pin)(pin)(pin)種(zhong)17個(ge)，其中(zhong)(zhong)國(guo)(guo)藥(yao)準字號品(pin)(pin)(pin)種(zhong)16個(ge)，保(bao)(bao)健食品(pin)(pin)(pin)品(pin)(pin)(pin)種(zhong)1個(ge)。3種(zhong)被(bei)列入(ru)《國(guo)(guo)家(jia)基(ji)本藥(yao)物目(mu)錄(lu)》（2018版(ban)(ban)(ban)(ban)），4種(zhong)被(bei)列入(ru)OTC甲類，5種(zhong)被(bei)列入(ru)《國(guo)(guo)家(jia)基(ji)本醫療(liao)保(bao)(bao)險、工傷保(bao)(bao)險和(he)(he)生育(yu)保(bao)(bao)險藥(yao)品(pin)(pin)(pin)目(mu)錄(lu)》（2019版(ban)(ban)(ban)(ban)）。主要(yao)產(chan)(chan)品(pin)(pin)(pin)有(you)(you)元(yuan)胡止(zhi)痛(tong)(tong)滴(di)(di)丸(wan)、七(qi)味溫陽膠囊、麻杏止(zhi)咳膠囊、酸(suan)棗仁(ren)油滴(di)(di)丸(wan)、消(xiao)栓通絡片(pian)(pian)、消(xiao)炎利(li)膽片(pian)(pian)、復方(fang)丹參片(pian)(pian)、斯(si)娜(na)格藥(yao)膜(mo)、黃芪當歸膠囊等。公(gong)司主打(da)產(chan)(chan)品(pin)(pin)(pin)為(wei)元(yuan)胡止(zhi)痛(tong)(tong)滴(di)(di)丸(wan)，為(wei)無成(cheng)癮性的(de)純(chun)中(zhong)(zhong)藥(yao)全科用(yong)藥(yao)，臨(lin)床(chuang)應(ying)用(yong)廣(guang)泛(fan)，對于治療(liao)行經腹痛(tong)(tong)、胃(wei)痛(tong)(tong)、脅痛(tong)(tong)和(he)(he)頭痛(tong)(tong)療(liao)效(xiao)顯著。連續被(bei)列入(ru)《國(guo)(guo)家(jia)基(ji)本用(yong)藥(yao)目(mu)錄(lu)》2009年(nian)版(ban)(ban)(ban)(ban)、2012年(nian)版(ban)(ban)(ban)(ban)、2018年(nian)版(ban)(ban)(ban)(ban)，入(ru)選國(guo)(guo)家(jia)中(zhong)(zhong)藥(yao)大(da)品(pin)(pin)(pin)種(zhong)、隴藥(yao)大(da)品(pin)(pin)(pin)種(zhong)，以其為(wei)核心的(de)《元(yuan)胡止(zhi)痛(tong)(tong)滴(di)(di)丸(wan)二(er)次(ci)(ci)開發研究》為(wei)國(guo)(guo)內首批(pi)中(zhong)(zhong)藥(yao)大(da)品(pin)(pin)(pin)種(zhong)二(er)次(ci)(ci)開發研究專著，為(wei)產(chan)(chan)品(pin)(pin)(pin)應(ying)用(yong)和(he)(he)臨(lin)床(chuang)實(shi)(shi)踐提供了重要(yao)的(de)理(li)論和(he)(he)實(shi)(shi)驗依(yi)據，產(chan)(chan)品(pin)(pin)(pin)市場前(qian)景(jing)廣(guang)闊(kuo)。
未來發展中(zhong)(zhong)，隴(long)神(shen)戎(rong)發將(jiang)緊緊把(ba)握國家和甘肅省大力扶持中(zhong)(zhong)醫(yi)藥(yao)(yao)(yao)產(chan)(chan)業(ye)發展、加快推進(jin)國家中(zhong)(zhong)醫(yi)藥(yao)(yao)(yao)產(chan)(chan)業(ye)發展綜合(he)試驗區建(jian)設、全面提升隴(long)藥(yao)(yao)(yao)產(chan)(chan)業(ye)整體(ti)實力，著力培育全省經濟(ji)轉型發展新增長極(ji)的政策機遇，全力打造(zao)產(chan)(chan)業(ye)鏈延(yan)伸(shen)、工藝(yi)技術升級及資源整合(he)創(chuang)新平臺，朝著中(zhong)(zhong)藥(yao)(yao)(yao)現(xian)代化(hua)、國際化(hua)目標，努力將(jiang)隴(long)神(shen)戎(rong)發建(jian)設成為集規范化(hua)中(zhong)(zhong)藥(yao)(yao)(yao)種植、中(zhong)(zhong)藥(yao)(yao)(yao)材(cai)深加工、新藥(yao)(yao)(yao)研發、現(xian)代中(zhong)(zhong)藥(yao)(yao)(yao)生產(chan)(chan)、藥(yao)(yao)(yao)品商貿物(wu)流為一(yi)體(ti)，具有完整產(chan)(chan)業(ye)鏈的隴(long)藥(yao)(yao)(yao)龍頭企業(ye)。
